Skip to content
Screener

Bioventus BVS Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Anika Therapeutics logo
Anika TherapeuticsANIK
$24.95M+0.9%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$2.89M+9.9%
Globus Medical logo
Globus MedicalGMED
7%-0.5pp
Enovis logo
EnovisENOV
$74.84M+14.8%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$49.91M+41.6%
Alphatec Holdings logo
Alphatec HoldingsATEC
$30.6M-10.0%

Other financials

Income statement

See full
Revenue$153.2M+3.8%
Gross profit$105.7M+3.5%
Operating income$19.1M+4.1%
Net income$33.4M+348%
EPS (diluted)$0.47+327%

Balance sheet

See full
Cash & equivalents$29.5M-10.5%
Total debt$263.7M-26.9%
Total equity$228.3M+41.6%
Total assets$673.3M-4.7%

Cash flow

See full
Operating cash flow$19.9M-23.4%
CapEx$960.0K+40.6%
Free cash flow$18.9M-25.1%

Valuation

See full
Market cap$1.17B+153%
Enterprise value$1.41B+78.0%
P/E21.6×
P/S+1.2×

Profitability

See full
Gross margin68.7%+1.1pp
Operating margin10%
Net margin9.4%+9.2pp
FCF margin16.2%+10.2pp

Returns & leverage

See full
Return on equity28%+27.5pp
Debt / equity1.2×-1.1×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The source filing: Bioventus’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:43 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001665988-26-000042
Line itemJune 27, 2026December 31, 2025
Finance lease liabilities—other long-term liabilities8,2288,729
Total financing lease liabilities$9,188$9,636
Weighted-average remaining lease term (years):
Operating leases2.02.4
Finance leases6.87.3
Weighted-average discount rate:
Operating leases5.2%5.2%
Finance leases8.1%8.1%

Item 1. Financial Statements (Unaudited)

FAQ

What is Bioventus's operating lease ROU assets?
Bioventus (BVS) reported operating lease ROU assets of 5.2% in Q2 2026.
How has Bioventus's operating lease ROU assets changed year-over-year?
Bioventus's operating lease ROU assets decreased by 0.0% year-over-year, from 5.2% to 5.2%.
What is the long-term trend for Bioventus's operating lease ROU assets?
Over 5 years (2020 to 2025), Bioventus's operating lease ROU assets has grown at a -98.0% compound annual growth rate (CAGR), from 1,496,100,000% to 5.2%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.

Ask your AI about Bioventus's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude